Strumento inattivo

Azioni Sucampo Pharmaceuticals, Inc.

Azioni

Durata

Periodo

Stile

SUCAMPO PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc	29/12/17
Apple : POINT Marchés-Wall Street finit peu changée, freinée par Apple	26/12/17
Wall Street slips on tech sector weakness	26/12/17
Mallinckrodt : to buy Sucampo for about $840 million	26/12/17
Apple : Les valeurs à suivre à Wall Street	26/12/17

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 Mrd
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 Mrd
ARGENX SE	+1,69%	22,15 Mrd
BIONTECH SE	-17,37%	21,02 Mrd
GENMAB A/S	-9,30%	18,15 Mrd
WUXI APPTEC CO., LTD.	-41,01%	16,74 Mrd
BEIGENE, LTD.	-14,85%	16,05 Mrd
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 Mrd
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 Mrd